The center houses the FDA’s “largest, most robust and probably most complex office,” according to CDER strategic communications specialist Aisha Coffey, whose job was affected. The “reduction in force ...

CDER Office of Drug Product Promotion director Tom Abrams told a Drug Information Association annual meeting session in June. FDA’s Brief Summary guidance is being re-worked, he said, “based on data ...

That responsibility will move to a new division in the CDER’s Office of Cardiology ... management, and communication of safety information across development programs and throughout the pre ...

The FDA’s Center for Drug Evaluation and Research (CDER) is consolidating its artificial ... offer a consistent voice in the drug center’s communications to the public and the industry on ...

In January 2024, the Office of Compliance at the FDA’s Center for Drug Evaluation Research (CDER) released its Annual Report for FY2023. The Annual Report contains several useful pieces of ...

These activities will include internal and external communications and collaboration ... lead for C3TI and deputy director of operations in the Office of New Drugs (OND), “CDER staff noted they would ...

The report covers the major achievements of the office during 2023, including notable drug approvals, publications, guidances, workshops, webinars, and meetings. FDA’s Center for Drug Evaluation and ...

In the latest Director’s Corner podcast, “Moving Forward in 2017,” Janet Woodcock, director of FDA's Center for Drug Evaluation and Research (CDER) detailed the center’s priorities for 2017. Woodcock ...